newsfilter
← Latest News
Business Wire·

Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note

The Waiver Exempts any determination of non-compliance associated to Nasdaq's Minimum Bid Price Requirement Rule Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") announces today the Company has